Dawson, R <br/><br/>
Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.  [electronic resource] 

 -  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  Jul 2015 
 - 780-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1815-7920 
<br/><br/><label>Standard No.: </label>10.5588/ijtld.14.0868  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antitubercular Agents--administration & dosage<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Ethambutol--therapeutic use<br/>Female<br/>Humans<br/>Isoniazid--therapeutic use<br/>Male<br/>Mycobacterium tuberculosis--drug effects<br/>Pyrazinamide--therapeutic use<br/>Rifampin--administration & dosage<br/>South Africa<br/>Sputum--microbiology<br/>Treatment Outcome<br/>Tuberculosis, Pulmonary--drug therapy<br/>Young Adult